AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ALLERGY THERAPEUTICS PLC

Board/Management Information Sep 27, 2013

7477_rns_2013-09-27_38c82bf7-3cbc-4d61-a2b5-56ba04d87029.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0929P

Allergy Therapeutics PLC

27 September 2013

27 September 2013

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Change of Adviser

Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, is pleased to announce the appointment, with immediate effect, of Peel Hunt LLP as its Nominated Adviser and Broker.

-Ends-

For further information

Allergy Therapeutics +44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer

Ian Postlethwaite Finance Director
Peel Hunt LLP +44 (0) 20 7418 8900
James Steel/Dr Vijay Barathan

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPFMGZLNNZGFZG

Talk to a Data Expert

Have a question? We'll get back to you promptly.